Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Urinary Incontinence, Urge

• Lidocaine Patches Prior to Percutaneous Nerve Evaluation
• Single-Dose Versus Multi-Dose Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
• Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
• The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder
• TReating Incontinence for Underlying Mental and Physical Health
• Intradetrusor Botulinum Toxin A: Are Less Injections Better?
• Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS
• A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder
• Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO
• Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
• Minimizing Pain During Office Intradetrussor Botox Injection
• URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence
• Sling vs Botox for Mixed Incontinence
• Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
• Oral vs Intravesical Analgesia for Office Bladder Botox Injections
• Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence
• Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid
• Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
• Treatment of Incontinence Without Memory Problems
• Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.
• Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
• Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
• Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
• Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa
• Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
• Incontinence & Intimate Partners: Assessing the Contribution of Treatment
• Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
• Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
• Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency
• Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence
• Anticholinergic vs. Botox Comparison Study
• The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects
• Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
• Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)
• Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder
• Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
• Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence
• A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence
• Over Active Bladder Instillation Study - Botox
• SSR240600C Treatment in Women With Overactive Bladder
• Pharmacological vs Surgical Treatment for Mixed Incontinence
• Refractory Urge Incontinence and Botox Injections
• A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence
• A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
• A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.
• A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence
• Enhancing Conservative Treatment for Urge Incontinence
• MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.